Toft BG - Search Results

1

Exercise training to increase tumour natural killer-cell infiltration in men with localised prostate cancer: a randomised controlled trial.

Djurhuus SS, Simonsen C, Toft BG, Thomsen SN, Wielsøe S, Røder MA, Hasselager T, Østergren PB, Jakobsen H, Pedersen BK, Hojman P, Brasso K, Christensen JF. Djurhuus SS, et al. Among authors: toft bg. BJU Int. 2023 Jan;131(1):116-124. doi: 10.1111/bju.15842. Epub 2022 Jul 18. BJU Int. 2023. PMID: 35753072 Free PMC article. Clinical Trial.

2

Effects of acute exercise training on tumor outcomes in men with localized prostate cancer: A randomized controlled trial.

Djurhuus SS, Schauer T, Simonsen C, Toft BG, Jensen ARD, Erler JT, Røder MA, Hojman P, Brasso K, Christensen JF. Djurhuus SS, et al. Among authors: toft bg. Physiol Rep. 2022 Oct;10(19):e15408. doi: 10.14814/phy2.15408. Physiol Rep. 2022. PMID: 36199257 Free PMC article. Clinical Trial.

3

ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer.

Berg KD, Brasso K, Thomsen FB, Røder MA, Holten-Rossing H, Toft BG, Iversen P, Vainer B. Berg KD, et al. Among authors: toft bg. J Clin Pathol. 2015 Oct;68(10):788-94. doi: 10.1136/jclinpath-2015-202894. Epub 2015 Jun 9. J Clin Pathol. 2015. PMID: 26060265

4

Diagnostic characteristics of lethal prostate cancer.

Helgstrand JT, Røder MA, Klemann N, Toft BG, Brasso K, Vainer B, Iversen P. Helgstrand JT, et al. Among authors: toft bg. Eur J Cancer. 2017 Oct;84:18-26. doi: 10.1016/j.ejca.2017.07.007. Epub 2017 Aug 2. Eur J Cancer. 2017. PMID: 28779631

5

Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer.

Kristensen G, Røder MA, Berg KD, Elversang J, Iglesias-Gato D, Moreira J, Toft BG, Brasso K. Kristensen G, et al. Among authors: toft bg. APMIS. 2018 Oct;126(10):804-813. doi: 10.1111/apm.12886. Epub 2018 Sep 6. APMIS. 2018. PMID: 30191621

6

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors.

Kristensen G, Strand SH, Røder MA, Berg KD, Toft BG, Høyer S, Borre M, Sørensen KD, Brasso K. Kristensen G, et al. Among authors: toft bg. Int J Mol Sci. 2019 Feb 27;20(5):1025. doi: 10.3390/ijms20051025. Int J Mol Sci. 2019. PMID: 30818754 Free PMC article.

7

Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis.

Kristensen G, Berg KD, Toft BG, Stroomberg HV, Nolley R, Brooks JD, Brasso K, Roder MA. Kristensen G, et al. Among authors: toft bg. J Clin Pathol. 2019 Oct;72(10):696-704. doi: 10.1136/jclinpath-2019-205940. Epub 2019 Jul 22. J Clin Pathol. 2019. PMID: 31331953

8

AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy.

Winther MD, Kristensen G, Stroomberg HV, Berg KD, Toft BG, Brooks JD, Brasso K, Røder MA. Winther MD, et al. Among authors: toft bg. Diagnostics (Basel). 2020 Jul 27;10(8):520. doi: 10.3390/diagnostics10080520. Diagnostics (Basel). 2020. PMID: 32726925 Free PMC article.

9

Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re-evaluation.

Berg KD, Toft BG, Røder MA, Brasso K, Vainer B, Iversen P. Berg KD, et al. Among authors: toft bg. APMIS. 2011 Apr;119(4-5):239-46. doi: 10.1111/j.1600-0463.2011.02723.x. Epub 2011 Mar 22. APMIS. 2011. PMID: 21492223

10

Is it possible to predict low-volume and insignificant prostate cancer by core needle biopsies?

Berg KD, Toft BG, Røder MA, Brasso K, Vainer B, Iversen P. Berg KD, et al. Among authors: toft bg. APMIS. 2013 Apr;121(4):257-65. doi: 10.1111/j.1600-0463.2012.02965.x. Epub 2012 Aug 23. APMIS. 2013. PMID: 23030402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page